These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Association of bronchodilator agents and mucolytics in aerosol therapy of chronic bronchopathies]. Olivieri D; Brancaccio L; Bocchino M Handchirurgie; 1974; 29(2):138-46. PubMed ID: 4452486 [No Abstract] [Full Text] [Related]
3. [The clinical pharmacology of drugs for the therapy of the broncho-obstructive syndrome]. Zaĭtsev AA; Karpov OI Farmakol Toksikol; 1990; 53(3):80-3. PubMed ID: 2201567 [TBL] [Abstract][Full Text] [Related]
4. [Studies on a new bronchospasmolytic agent from the group of antihistaminics]. Herberg D; Utz G Dtsch Med Wochenschr; 1969 Jan; 94(4):153-7. PubMed ID: 4387343 [No Abstract] [Full Text] [Related]
5. [Mechanism of action and indications for administration of some bronchodilator agents]. Nikodýmová L; Růzicka J Cas Lek Cesk; 1971 Oct; 110(41):945-50. PubMed ID: 5112128 [No Abstract] [Full Text] [Related]
6. [Methods for the study of reversible bronchial obstruction]. Bianco S; Robuschi M; Petrigni G Arch Monaldi Mal Torace; 1989; 44(4-6):503-9. PubMed ID: 2577765 [No Abstract] [Full Text] [Related]
7. [Results obtained with bronchodilator aerosol of 1-(3,5 dehydroxyphenyl)-2-isopropylaminoethanol sulphate]. Ruiz Benítez G Rev Clin Esp; 1966 Aug; 102(4):305-10. PubMed ID: 5995634 [No Abstract] [Full Text] [Related]
8. [Trends in the general therapy of chronic aspecific bronchopneumopathies]. Nitti V Arch Monaldi; 1971; 26(3):203-16. PubMed ID: 5145194 [No Abstract] [Full Text] [Related]
9. [Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm]. Rozniecki J; Grabski W Pol Tyg Lek; 1975 Feb; 30(7):301-4. PubMed ID: 1118349 [No Abstract] [Full Text] [Related]
10. Evaluation of bronchodilators and mucolytic agents. Kamat SR J Postgrad Med; 1979 Jan; 25(1):1-3. PubMed ID: 458736 [No Abstract] [Full Text] [Related]
11. [Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics]. Starnegg Q Wien Med Wochenschr; 1971 May; 121(22):455-7. PubMed ID: 5092121 [No Abstract] [Full Text] [Related]
12. Inhalation therapy and bronchial drainage in the management of chronic lung diseases in children. Doershuk CF; Matthews LW Bull N Y Acad Med; 1972 May; 48(4):704-6. PubMed ID: 4503930 [No Abstract] [Full Text] [Related]
13. [Bronchial obstruction and its differentiated therapy in bronchopulmonary diseases]. Zamotaev IP; Shul'gin AV; Maksimova LN; Bulycheva NA; Golub' GA Sov Med; 1977 Dec; (12):19-23. PubMed ID: 23586 [No Abstract] [Full Text] [Related]
14. Metaproterenol, a new bronchodilator:: comparison with isoproterenol. Pelz HH Am J Med Sci; 1967 Mar; 253(3):321-4. PubMed ID: 6021691 [No Abstract] [Full Text] [Related]
15. [Contribution to the treatment of spastic bronchitis in infancy]. Habermann P Med Welt; 1968 May; 21():1342-4. PubMed ID: 5721333 [No Abstract] [Full Text] [Related]
16. Treatment of chronic obstructive bronchopulmonary disease in the aged. Lipman WH West Med Med J West; 1967; 8(3):73-5. PubMed ID: 6072167 [No Abstract] [Full Text] [Related]
17. [Contribution to bronchospasmolytic therapy in infants, children and adults]. Fladung H Med Welt; 1967 Mar; 11():654-6. PubMed ID: 5587156 [No Abstract] [Full Text] [Related]
18. The treatment of bronvho-pulmonary obstructive disease states. Lipman WH Med Times; 1967 Dec; 95(12):1295-302. PubMed ID: 6081119 [No Abstract] [Full Text] [Related]
19. [Treatment of spastic bronchitis with a new bronchospasmolytic agent]. Heller K Wien Med Wochenschr; 1972 Oct; 122(42):606-9. PubMed ID: 5081450 [No Abstract] [Full Text] [Related]